ESPR: the balance sheet

MyFinsight

For the year ending 2025-12-31, ESPR has $465,886K in assets. $767,851K in debts. $167,852K in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	167,852
Accounts receivable, net	140,190
Inventories, net	105,124
Prepaid clinical development costs	4,044
Prepaid inventory costs	40,864
Other prepaid and current assets	4,496
Total current assets	462,570
Property and equipment, gross	2,517
Less accumulated depreciation and amortization	2,179
Property and equipment, net	338
Right of use operating lease assets	2,922
Intangible assets	56
Total assets	465,886

Accounts payable	65,068
Convertible notes, net of issuance costs	0
Accrued clinical development costs	4,115
Accrued variable consideration	88,203
Other accrued liabilities	19,249
Royalty sale liability	87,596
Deferred revenue from collaborations	34,477
Operating lease liabilities	2,102
Total current liabilities	300,810
Convertible notes, net of issuance costs	97,260
Royalty sale liability	208,170
Long-term debt	152,219
Operating lease liabilities	653
Other long-term liabilities	8,739
Total liabilities	767,851
Common stock, 0.001 par value 480,000,000 shares authorized as of december31, 2025 and december31, 2024 247,210,341 shares issued at december31, 2025 and 197,846,661 shares issued at december31, 2024	245
Additional paid-in capital	1,376,499
Treasury stock, at cost 1,994,198 shares at december 31, 2025 and december 31, 2024	54,998
Accumulated other comprehensive loss	0
Accumulated deficit	-1,623,711
Total stockholders' deficit	-301,965
Total liabilities and stockholders' deficit	465,886

Unit: Thousand (K) dollars (except for numbers of shares and EPS).